Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

OncoCyte Corp (OCX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow OncoCyte's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2.455 -0.055    -2.19%
15:59:59 - Closed. Currency in USD ( Disclaimer )
After Hours
2.410
-0.045
-1.833%
17:37:07 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 22,677
  • Bid/Ask: 2.260 / 2.660
  • Day's Range: 2.450 - 2.553
OncoCyte 2.455 -0.055 -2.19%

OCX User Rankings

 
Users ranking according to the performance of their sentiments for the OncoCyte Corp stock.
RankUsernameTotalClosedWinningWin %Chg. %
1davide garulli222100+55.27%
2Jean Marc Bergeron222100+54.48%
3Evgeniy Igonin111100+49.77%
4Ali Afzali111100+43.31%
5Joaquin Pearce111100+42.15%
6vbg99111100+41.15%
7Lindsay Graham111100+40.89%
8רפאל לירי111100+39.95%
9Dennis Caldito111100+38.68%
10Nick Tang111100+37.55%
11Antonio Cabello111100+34.08%
12Mateo Broilo222100+28.84%
13Remzi Bahtiyar222100+20.65%
14Steven Boutwell111100+18.47%
15Lior Benichou111100+12.31%
16M.N. Youshei111100+9.95%
17Denyaa Alhob111100+7.42%
18Alex Nobili111100+6.85%
19Daniel Lee111100+5.52%
20Ivica Maurovic111100+5.43%
21Wojciech Zimnicki111100+4.46%
22Markus Pöpping111100+4.14%
23Marcel Jucker111100+2.55%
24Dharen Gasidan1000+1.14%
25Mitchell Ellis11000%
26JeanBastien Vaillancourt22000%
27Alexandre Bavastro10000%
28Ricky Asrula1100-2.71%
29Gregory Samson1100-4.22%
30Daniel Lorenzini1100-5.78%
31Rambabu Verma1100-9.33%
32Abbas Reza1100-10.45%
33Дамир Мурзабаев1100-18.66%
34Binod Nayyar1100-20.37%
35Rafael millan1100-23.75%
36francis loos1100-24.29%
37Geonho Kim2200-29.44%
38Shree boru inc Yogesh1100-30.33%
39Enrique Lucas1100-31.43%
40Netanel Tapiro1100-34.64%
41سلطان المحياوي1100-35.33%
42Robbert Kuipers88562.5-36.24%
43Pasquale DeMarco1100-36.56%
44Reinaldo Singh2200-36.63%
45Ernando Bizello1100-36.76%
46Cora So1100-38%
47Shea Brandon1100-38.27%
48sang do1100-39.12%
49Andrena Oglesby1100-39.79%
50Covest Co1100-39.86%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

OCX Comments

Write your thoughts about OncoCyte Corp
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Marielle Velasco
Marielle Velasco Dec 17, 2020 6:51PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Where is thus going
Tariq Matloob
Tariq Matloob Dec 16, 2020 7:07AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Oncocyte Soars on Licensing Deal With Chinese FirmThe cancer detection company said it has licensed a lung cancer test to China’s Burning Rock Biotech.DAN WEIL20 HOURS AGO
Sebastian Melin
Sebastian Melin Dec 15, 2020 9:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
just stopped dead in its tracks? :(
Brijesh Patel
Brijesh Patel Dec 15, 2020 9:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
yeah it did
Khalil Borashed
Khalil Borashed Oct 01, 2020 9:50AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
estimates have projected may approach $15 billion by 2025. yahoo finace the source
Khalil Borashed
Khalil Borashed Oct 01, 2020 9:49AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The agreement will allow Oncocyte to increase its test portfolio in the U.S. to address a broader care continuum.
Kelly Robinson
Kelly Robinson Feb 26, 2020 10:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
one if the most inactive stocks. we would like some positive news.
Ramiro Marrero
Ramiro Marrero Jun 25, 2019 7:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any news expected soon? What are the future potential of this company. I am considering buy 1k shares? Thanks
Sean Mabingnay
Sean Mabingnay Jan 29, 2019 2:32PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
to God be the glory
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email